EU regulator recommends against Merck’s COVID drug



The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use recommended against Merck & Co. Inc.’s drug Lagevrio (molnupiravir) treatment for COVID-19 on Friday.

Accord…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento